Status:
COMPLETED
Tai Chi Exercise in Patients with Heart Failure
Lead Sponsor:
Abant Izzet Baysal University
Conditions:
Nursing Caries
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Aim: The aim of the present study is to examine with B-type natriuretic peptide (pro-BNP) and echocardiographic parameters and to measure life quality the effects of the 12-week Tai-Chi exercise progr...
Detailed Description
The aim of the present study is to examine with B-type natriuretic peptide (pro-BNP) and echocardiographic parameters and to measure life quality the effects of the 12-week Tai-Chi exercise program on...
Eligibility Criteria
Inclusion
- 18 years and over,
- Diagnosed as chronic heart failure by the physician,
- Left ventricular ejection fraction (LVEF) \<40%, proven by echocardiography in the past two years,
- New York Heart Association (NYHA) class II and III,
- Sinus rhythm is observed in electrocardiography (ECG),
- Blood pressure values measured before Tai Chi session were 120-160 mmHg for systolic pressure and 80-110 mmHg for diastolic pressure,
- No current anxiolytic or hypnotic treatment,
- Have no psychiatric problems,
- Verbal communication can be established,
- Those who understand and speak Turkish,
- No speech, hearing and vision loss,
- There is no physical limitation that prevents the exercise of standing,
- They have never experienced Tai Chi exercise before,
- Individuals who volunteer to participate in the Tai Chi program during the study
Exclusion
- Having unstable angina pectoris, myocardial infarction or major cardiac surgery in the past three months,
- Experiencing dyspnea and exercise tolerance that worsen during rest,
- NYHA class I and IV,
- Type B natriuretic peptide level measured in the last three months is 100 and above,
- Blood pressure values measured before the Tai Chi session are\> 120 mmHg or \<160 mmHg for systolic pressure and\> 80 mmHg or \<110 mmHg for diastolic pressure,
- Has hemodynamically significant heart valve disease,
- Having dysrhythmia problems such as ventricular tachyarrhythmia, atrial fibrillation,
- Has a history of cardiac resynchronization therapy in the past 3 months,
- Having chronic diseases such as chronic pulmonary disease and renal failure,
- With uncontrolled diabetes (Hemoglobin A1C ≥ 7 mg / dl),
- Diagnosed with thrombophlebitis,
- Has a history of cardiac transplantation and cardiac device therapy (cardiac pacemaker, implantable cardioverter defibrillator),
- Having physical limitations that prevent standing exercise,
- Do not understand and speak Turkish,
- Speech, hearing and vision loss,
- Individuals who do not volunteer to participate in the Tai Chi program during the study
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2021
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04445753
Start Date
January 1 2020
End Date
December 21 2021
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bolu Abant Izzet Baysal University Izzet Baysal Training and Research Hospital
Bolu, Bolu, Turkey (Türkiye), 14280